Suboptimal splice sites of equine infectious anaemia virus control Rev responsiveness

Journal of General Virology

Volumn 81, Issue 5, 2000, Pages 1265-1272

  Rosin Arbesfeld, Rina ^a   Yaniv, Abraham ^a   Gazit, Arnona ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; CIS ACTING ELEMENT; REV PROTEIN; VIRUS PROTEIN; VIRUS RNA;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; EQUINE INFECTIOUS ANEMIA VIRUS; GENE FUNCTION; GENE LOCATION; LENTIVIRINAE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; REPORTER GENE; RNA SPLICING; RNA TRANSCRIPTION; SITE DIRECTED MUTAGENESIS; VIRUS GENOME; VIRUS REPLICATION;

ANIMALIA; EQUIDAE; EQUINE INFECTIOUS ANEMIA VIRUS; LENTIVIRUS; RNA VIRUSES;

EID: 0034052453     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-81-5-1265     Document Type: Article

References (28)

1. Belshan, M., Harris, M. E., Shoemaker, A. E., Hope, T. J. & Carpenter, S. (1998). Biological characterization of Rev variation in equine infectious anemia virus. Journal of Virology 72, 4421-4426.
2. Borg, K. T., Favaro, J. P. & Arrigo, S. J. (1997). Involvement of human immunodeficiency virus type-1 splice sites in the cytoplasmic accumulation of viral RNA. Virology 236, 95-103.
3. Cochrane, A. W., Jones, K. S., Beidas, S., Dillon, P. J., Skalka, A. M. & Rosen, C. A. (1991). Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression. Journal of Virology 65, 5305-5313.
4. Cullen, B. R. (1998). Retroviruses as model systems for the study of nuclear RNA export pathways. Virology 249, 203-210.
5. Fridell, R. A., Partin, K. M., Carpenter, S. & Cullen, B. R. (1993). Identification of the activation domain of equine infectious anemia virus rev. Journal of Virology 67, 7317-7323.
6. Gontarek, R. R. & Derse, D. (1996). Interactions among SR proteins, an exonic splicing enhancer, and a lentivirus Rev protein regulate alternative splicing. Molecular and Cellular Biology 16, 2325-2331.
7. German, C. M., Merlino, G. T., Willingham, M. C., Pastan, I. & Howard, B. H. (1982). The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection. Proceedings of the National Academy of Sciences, USA 79, 6777-6781.
8. Harris, M. E., Gontarek, R. R., Derse, D. & Hope, T. J. (1998). Differential requirements for alternative splicing and nuclear export functions of equine infectious anemia virus Rev protein. Molecular and Cellular Biology 18, 3889-3899.
9. Huffman, K. M. & Arrigo, S. J. (1997). Identification of cis-acting repressor activity within human immunodeficiency virus type 1 protease sequences. Virology 234, 253-260.
10. Kawakami, T., Sherman, L., Dahlberg, J., Gazit, A., Yaniv, A., Tronick, S. R. & Aaronson, S. A. (1987). Nucleotide sequence analysis of equine infectious anemia proviral DNA. Virology 158, 300-312.
11. Kingsman, S. M. & Kingsman, A. J. (1996). The regulation of human immunodeficiency virus type-1 gene expression. European Journal of Biochemistry 240, 491-507.
12. Maldarelli, F., Martin, M. A. & Strebel, K. (1991). Identification of posttranscriptionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: novel level of gene regulation. Journal of Virology 65, 5732-5743.
13. Malim, M. H., Hauber, J., Fenrick, R. & Cullen, B. R. (1988). Immunodeficiency virus Rev trans-activator modulates the expression of the viral regulatory genes. Nature 335, 181-183.
14. Mancuso, V. A., Hope, T. J., Zhu, L., Derse, D., Phillips, T. & Parslow, T. G. (1994). Posttranscriptional effector domains in the Rev proteins of feline immunodeficiency virus and equine infectious anemia virus. Journal of Virology 68, 1998-2001.
15. Martarano, L., Stephens, R., Rice, N. & Derse, D. (1994). Equine infectious anemia virus trans-regulatory protein Rev controls viral mRNA stability, accumulation, and alternative splicing. Journal of Virology 68, 3102-3111.
16. Meyer, B. E., Meinkoth, J. L. & Malim, M. H. (1996). Nuclear transport of human immunodeficiency virus type 1, visna virus, and equine infectious anemia virus Rev proteins: identification of a family of transferable nuclear export signals. Journal of Virology 70, 2350-2359.
17. Neumann, J. R., Morency, C. A. & Russian, K. O. (1987). A novel rapid assay for chloramphenicol acetyltransferase gene expression. Biotechniques 5, 444-447.
18. Noiman, S., Yaniv, A., Sherman, L., Tronick, S. R. & Gazit, A. (1990). Pattern of transcription of the genome of equine infectious anemia virus. Journal of Virology 64, 1839-1843.
19. Noiman, S., Yaniv, A., Tsach, T., Miki, T., Tronick, S. R. & Gazit, A. (1991). The Tat protein of equine infectious anemia virus is encoded by at least three types of transcripts. Virology 184, 521-530.
20. Otero, G. C., Harris, M. E., Donello, J. E. & Hope, T. J. (1998). Leptomycin B inhibits equine infectious anemia virus Rev and feline immunodeficiency virus rev function but not the function of the hepatitis B virus posttranscriptional regulatory element. Journal of Virology 72, 7593-7597.
21. Pollard, V. W. & Malim, M. H. (1998). The HIV-1 Rev protein. Annual Review of Microbiology 52, 491-532.
22. Rosen, C. A., Terwilliger, E., Dayton, A., Sodroski, J. G. & Haseltine, W. A. (1988). Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus. Proceedings of the National Academy of Sciences, USA 85, 2071-2075.
23. Rosin-Arbesfeld, R., Rivlin, M., Noiman, S., Mashiah, P., Yaniv, A., Miki, T., Tronick, S. R. & Gazit, A. (1993). Structural and functional characterization of rev-like transcripts of equine infectious anemia virus. Journal of Virology 67, 5640-5646.
24. Rosin-Arbesfeld, R., Willbold, D., Yaniv, A. & Gazit, A. (1998). The Tat protein of equine infectious anemia virus (EIAV) activates cellular gene expression by read-through transcription. Gene 219, 25-35.
25. Schoborg, R. V. & Clements, J. E. (1996). Definition of the RRE binding and activation domains of the caprine arthritis encephalitis virus Rev protein. Virology 226, 113-121.
26. Schwartz, S., Felber, B. K. & Pavlakis, G. N. (1992 a). Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein. Journal of Virology 66, 150-159.
27. Schwartz, S., Campbell, M., Nasioulas, G., Harrison, J., Felber, B. K. & Pavlakis, G. N. (1992 b). Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression. Journal of Virology 66, 7176-7182.
28. Tan, W., Schalling, M., Zhao, C., Luukkonen, M., Nilsson, M., Fenyo, E. M., Pavlakis, G. N. & Schwartz, S. (1996). Inhibitory activity of the equine infectious anemia virus major 5′ splice site in the absence of Rev. Journal of Virology 70, 3645-3658.